Known targets — ChEMBL curated mechanism
ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 known ✓ | P08172 | 3/20 | 0.91 |
| ▸ | CHRM1 known ✓ | P11229 | 3/20 | 0.91 |
| ▸ | CHRM3 known ✓ | P20309 | 3/20 | 0.91 |
| ▸ | SLC6A2 known ✓ | P23975 | 3/20 | 0.91 |
| ▸ | SLC6A3 known ✓ | Q01959 | 3/20 | 0.91 |
| ▸ | ACHE known ✓ | P22303 | 2/20 | 0.91 |
| ▸ | BDKRB2 known ✓ | P30411 | 1/20 | 0.89 |
| ▸ | SMN1; SMN2 | Q16637 | 6/20 | 0.91 |
| ▸ | MEN1 | O00255 | 5/20 | 0.91 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.91 |
| ▸ | HIF1A | Q16665 | 5/20 | 0.91 |
| ▸ | HTT | P42858 | 5/20 | 0.91 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.91 |
| ▸ | LMNA | P02545 | 4/20 | 0.91 |
| ▸ | TP53 | P04637 | 4/20 | 0.91 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.91 |
| ▸ | APAF1 | O14727 | 3/20 | 0.91 |
| ▸ | USP2 | O75604 | 3/20 | 0.91 |
| ▸ | MAPT | P10636 | 3/20 | 0.91 |
| ▸ | RAD52 | P43351 | 3/20 | 0.91 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Benzethonium SCHEMBL27797280 | 0.95 | SMN1; SMN2 (1.00) | SMN1; SMN2MEN1KMT2AHIF1AHTT | |
| Benzethonium SCHEMBL21713 | 0.95 | SMN1; SMN2 (1.00) | SMN1; SMN2MEN1KMT2AHIF1AHTT | |
| Benzethonium SCHEMBL976363 | 0.94 | SMN1; SMN2 (0.98) | SMN1; SMN2MEN1KMT2AHIF1AHTT | |
| Benzethonium SCHEMBL13278583 | 0.94 | SMN1; SMN2 (0.98) | SMN1; SMN2MEN1KMT2AHIF1AHTT | |
| Benzethonium SCHEMBL10341422 | 0.94 | SMN1; SMN2 (0.98) | SMN1; SMN2MEN1KMT2AHIF1AHTT | |
| Benzethonium SCHEMBL28210479 | 0.94 | SMN1; SMN2 (0.98) | SMN1; SMN2MEN1KMT2AHIF1AHTT | |
| Benzethonium SCHEMBL7271857 | 0.94 | SMN1; SMN2 (0.98) | SMN1; SMN2MEN1KMT2AHIF1AHTT | |
| Benzethonium SCHEMBL122985 | 0.94 | SMN1; SMN2 (1.00) | SMN1; SMN2MEN1KMT2AHIF1AHTT | |
| Benzethonium SCHEMBL976365 | 0.93 | SMN1; SMN2 (0.96) | SMN1; SMN2MEN1KMT2AHIF1AHTT | |
| Benzethonium SCHEMBL1951703 | 0.93 | SMN1; SMN2 (0.98) | SMN1; SMN2MEN1KMT2AHIF1AHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230022721-A1 | COMPOSITIONS AND METHODS FOR INHIBITION AND INTERRUPTION OF BIOFILM FORMATION | DENTSPLY SIRONA INC. (US) | 2023-01-26 | — | — | US | disclosed |
| US-20170280725-A1 | COMPOSITIONS AND METHODS FOR INHIBITION AND INTERRUPTION OF BIOFILM FORMATION | DENTSPLY SIRONA INC (US) | 2017-10-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170280725-A1 | COMPOSITIONS AND METHODS FOR INHIBITION AND INTERRUPTION OF BIOFILM FORMATION | FGB, TFPI, F12 | CHRM2 4765/4885CHRM1 4538/4885CHRM3 4649/4885 |
| US-20230022721-A1 | COMPOSITIONS AND METHODS FOR INHIBITION AND INTERRUPTION OF BIOFILM FORMATION | FGB, TFPI, F12 | CHRM2 4765/4885CHRM1 4538/4885CHRM3 4649/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.